다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

MRUS

Merus NV (MRUS)

Merus NV

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:MRUS

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/13	06:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRUS	Merus NV
2024/06/07	05:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRUS	Merus NV
2024/06/04	03:30	GlobeNewswire Inc.	Merus’ MCLA-129 Demonstrates Promising Single-Agent Efficiency in METex14 NSCLC in Poster Presentation at the 2024 ASCO® Annual Meeting	NASDAQ:MRUS	Merus NV
2024/06/03	01:30	GlobeNewswire Inc.	Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 2024 ASCO® Annual Meeting	NASDAQ:MRUS	Merus NV
2024/05/31	06:21	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:MRUS	Merus NV
2024/05/30	10:30	GlobeNewswire Inc.	Merus Announces Pricing of Upsized Public Offering of Common Shares	NASDAQ:MRUS	Merus NV
2024/05/29	21:00	GlobeNewswire Inc.	Merus to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference	NASDAQ:MRUS	Merus NV
2024/05/29	05:29	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:MRUS	Merus NV
2024/05/29	05:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MRUS	Merus NV
2024/05/29	05:01	GlobeNewswire Inc.	Merus N.V. Announces Proposed Public Offering of Common Shares	NASDAQ:MRUS	Merus NV
2024/05/28	20:00	GlobeNewswire Inc.	Merus’ Petosemtamab in Combination with Pembrolizumab Interim Data Demonstrates Robust Response Rate and Favorable Safety Profile in 1L r/m HNSCC	NASDAQ:MRUS	Merus NV
2024/05/24	06:00	GlobeNewswire Inc.	Merus Announces Publication of an Abstract on Petosemtamab with Pembrolizumab as 1L treatment of r/m HNSCC at the 2024 ASCO® Annual Meeting	NASDAQ:MRUS	Merus NV
2024/05/13	21:00	GlobeNewswire Inc.	Petosemtamab granted Breakthrough Therapy Designation by the U.S. FDA	NASDAQ:MRUS	Merus NV
2024/05/11	05:33	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:MRUS	Merus NV
2024/05/10	05:35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRUS	Merus NV
2024/05/10	05:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRUS	Merus NV
2024/05/10	05:30	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:MRUS	Merus NV
2024/05/10	05:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRUS	Merus NV
2024/05/10	05:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRUS	Merus NV
2024/05/10	05:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRUS	Merus NV
2024/05/10	05:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRUS	Merus NV
2024/05/10	05:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRUS	Merus NV
2024/05/09	05:15	GlobeNewswire Inc.	Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update	NASDAQ:MRUS	Merus NV
2024/05/08	21:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MRUS	Merus NV
2024/05/07	05:05	GlobeNewswire Inc.	Merus Announces U.S. FDA Acceptance and Priority Review of Biologics License Application for Zeno for the Treatment of NRG1+ NSCLC and PDAC	NASDAQ:MRUS	Merus NV
2024/04/09	01:00	GlobeNewswire Inc.	Merus Presents Preclinical Data Demonstrating Efficacy of Zeno in Cancer Models with High NRG1 Expression at the AACR Annual Meeting 2024	NASDAQ:MRUS	Merus NV
2024/04/03	21:00	GlobeNewswire Inc.	Merus to Participate in a Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference	NASDAQ:MRUS	Merus NV
2024/03/06	22:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MRUS	Merus NV
2024/03/06	22:00	Business Wire	Gilead and Merus Announce Collaboration to Discover Novel Antibody-Based Trispecific T-Cell Engagers	NASDAQ:MRUS	Merus NV
2024/03/06	06:30	GlobeNewswire Inc.	Merus Announces Publication of an Abstract for Presentation at the AACR Annual Meeting 2024: Zeno is effective in cancer models with high NRG1 expression	NASDAQ:MRUS	Merus NV

검색 관련기사 보기:NASDAQ:MRUS

1 2 3 4 5 6 7 8 9 10 다음 >>

Energy Select Sector SPDR

US Dollar vs Yen

Invesco QQQ Trust Series 1

Deutsche Telekom (QX)

US Dollar vs Euro

Verizon Communications

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관